The Wall Street Journal: Drug Rebates Aren’t ‘Kickbacks’
September 17, 2018
The Weekly Standard: A Great Way to Increase Drug Costs Even More
STAT News: Rush to end drug rebates may be bad for patients, payers, and pharma
September 07, 2018
Fact: PBMs leverage competition and negotiate rebates from drug manufacturers to lower drug costs.